Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Cash from Financing Activities of $26000.0 for Q3 2025, up 8.33% quarter-over-quarter from $24000.0 in Q2 2025.
Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash from Financing Activities for 6 consecutive years, with $26000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash from Financing Activities changed N/A year-over-year to $26000.0; the TTM figure through Sep 2025 stood at $73000.0 (up 102.78% YoY), while the FY2024 annual figure was $8000.0, down 99.98% from the prior year.
- Cash from Financing Activities advanced to $26000.0 in Q3 2025 per RBOT's latest filing, from $24000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $191.1 million in Q3 2021 and bottomed at -$486000.0 in Q4 2021.
- Historically, Cash from Financing Activities has averaged $14.5 million across 5 years, with a median of $59000.0 in 2022.
- Annual changes were most pronounced in 2021 — Cash from Financing Activities sank 100.14% — and 2023, when it jumped 44133.0%.
- Vicarious Surgical's Cash from Financing Activities stood at -$486000.0 in 2021, then jumped by 1913.17% to $8.8 million in 2022, then sank by 99.61% to $34000.0 in 2023, then sank by 82.35% to $6000.0 in 2024, then jumped by 333.33% to $26000.0 in 2025.
- Business Quant data shows RBOT's Cash from Financing Activities at $26000.0 in Q3 2025, $24000.0 in Q2 2025, and $17000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 44.23 Mn |
| Sep 30, 2023 | 44.23 Mn |
| Jun 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 162,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 8.81 Mn |
| Dec 31, 2022 | 8.81 Mn |